Hikma Pharmaceuticals PLC (HKMPY) Sales/ Trading Statement Call Transcript
UK's Hikma Pharmaceuticals reiterates 2026 outlook despite higher costs from Iran war
Hikma Pharmaceuticals PLC (HKMPY) Q4 2025 Earnings Call Prepared Remarks Transcript
Hikma Pharmaceuticals PLC (HKMPY) Q4 2025 Earnings Call Transcript
Hikma Pharma tumbles on softer guidance as buyback fails to soften pill
Financial Review: Century Therapeutics (NASDAQ:IPSC) and Hikma Pharmaceuticals (OTCMKTS:HKMPF)
Head to Head Contrast: Hikma Pharmaceuticals (OTCMKTS:HKMPF) vs. ProPhase Labs (NASDAQ:PRPH)
Hikma falls to three-year low as CEO steps down with immediate effect
Hikma falls to three-year low as CEO steps down with immediate effect
Diamond Hill International Strategy Q3 2025 Portfolio Activity
Hikma Pharmaceuticals: Due a dose of confidence
Hikma Pharmaceuticals PLC (HKMPY) Shareholder/Analyst Call Transcript
Hikma Pharma tumbles as injectables guidance cut
If Hikma can reassure with quarterly update it should be catalyst, says broker
Hikma: US bank says cheap valuation still trumps margin worries
Hikma: Valuation support despite mixed half-year
Hikma Pharmaceuticals PLC (HKMPF) Q2 2025 Pre Recorded Earnings Call Transcript
Hikma Pharmaceuticals PLC (HKMPF) Q2 2025 Q&A Earnings Call Transcript
Hikma Pharma tumbles as first-half profits dented by shifting product mix
Hikma Pharmaceuticals tumbles after injectables margin outlook cut
Hikma Pharma jumps as it hikes medium-term outlook
Hikma Pharmaceuticals PLC (HKMPF) Q4 2024 Earnings Call Pre-Recorded (Transcript)
Hikma shares fall 5% as stock succumbs to profit taking after strong results and outlook statement
Hikma Pharmaceuticals (HKMPF) Upgraded to Buy: Here's What You Should Know
Hikma Pharmaceuticals PLC (HKMPF) Q2 2024 Pre-Recorded Presentation Transcript
Hikma Pharmaceuticals rallies following bullish first-half earnings
U.K. Top 40 Quality Dividend Stocks: Summer 2024
Hikma beefs up complex manufacturing skillset with Xellia assets
U.K. Top 40 Quality Dividend Stocks: Q2 2024
Hikma Pharmaceuticals PLC (HKMPF) Q4 2023 Earnings Call Transcript
Hikma divi boost sends stock 5% higher
Hikma Pharma resolves US opioid litigation
Ad firm Publicis, drugmaker Hikma settle US opioid cases for $500 million
U.K. Dividend Stocks Portfolio: 2023 Year-End Review
Hikma Pharmaceuticals upgrades guidance for all segments except injectables
Selling Hikma Pharmaceuticals After A 40% Share Price Gain In 7 Months
Hikma Pharmaceuticals PLC (HKMPF) Q4 2022 Earnings Call Transcript
Hikma Pharmaceuticals higher as Citi analysts revise target price
Hikma Pharmaceuticals launches generic version of narcolepsy treatment Xyrem in US
Hikma Pharmaceuticals Plc (HKMPF) 2022 Interim Results - Earnings Call Transcript
Hikma Pharmaceuticals loses CEO
Hikma Pharmaceuticals PLC (HKMPF) CEO Sigurdur Olafsson on Q4 2021 Results - Earnings Call Transcript
Hikma Pharmaceuticals sales grow 9%, announces US$300mln share buyback
Hikma Pharmaceuticals to buy US generic sterile injectables producer Custopharm for US$375mln
Hikma Pharmaceuticals' (HKMPF) CEO Sigurdur Olafsson on Q2 2021 Results - Earnings Call Transcript
Hikma Pharmaceuticals first half revenue and profits grow
Here's Why "Trend" Investors Would Love Betting on Hikma Pharmaceuticals Plc (HKMPF)
Hikma Pharmaceuticals receives US approval for opioid overdose treatment Kloxxado
Hikma Pharmaceuticals PLC (HKMPF) CEO Siggi Olafsson on Q4 2020 Results - Earnings Call Transcript
Hikma Pharmaceuticals revenue growth expectations come in below consensus